Evidence map›Paper›PMID 37443124›Full record

ArticleJournal of pharmaceutical policy and practice2023

Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation.

Petra Brhlikova, Thilagawathi Abi Deivanayagam, Zaheer-Ud-Din Babar, Claudia Garcia Serpa Osorio-de-Castro, Rosângela Caetano, Allyson M Pollock

Abstract read
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. The Potential Role of Ecotoxicological Data in National Essential Medicine Lists: A Cross-Sectional Analysis.International journal of environmental research and public health · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Petra BrhlikovaPopulation Health Sciences Institute, Newcastle University, Baddiley-Clark Bldg, Newcastle Upon Tyne, NE2 4AX, UK. petra.sevcikova@newcastle.ac.uk.ORCID http://orcid.org/0000-0003-2085-0304
Thilagawathi Abi DeivanayagamLancaster Medical School, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.ORCID http://orcid.org/0000-0002-1130-2333
Zaheer-Ud-Din BabarDepartment of Pharmacy, University of Huddersfield, Huddersfield, UK.ORCID http://orcid.org/0000-0003-1051-3240
Claudia Garcia Serpa Osorio-de-CastroDepartamento de Política de Medicamentos E Assistência Farmacêutica, Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0003-4875-7216
Rosângela CaetanoDepartamento de Política, Planejamento E Administração Em Saúde, Instituto de Medicina Social, Universidade Do Estado Do Rio de Janeiro, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0003-1480-2453
Allyson M PollockPopulation Health Sciences Institute, Newcastle University, Baddiley-Clark Bldg, Newcastle Upon Tyne, NE2 4AX, UK.ORCID http://orcid.org/0000-0002-7388-3110

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37443124
PMCPMC10347820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.